Cardiovascular Systems Inc. (NASDAQ:CSII)’s share price rose 5.7% on Monday . The company traded as high as $24.25 and last traded at $23.88, with a volume of 884,636 shares. The stock had previously closed at $22.60.

CSII has been the subject of a number of research analyst reports. Needham & Company LLC increased their price target on Cardiovascular Systems from $16.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, May 5th. Leerink Swann reiterated a “market perform” rating and set a $15.00 price target (up from $13.00) on shares of Cardiovascular Systems in a report on Saturday, May 7th. Zacks Investment Research upgraded Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $21.00 price target for the company in a report on Monday, July 4th. Finally, Bank of America Corp. upgraded Cardiovascular Systems from an “underperform” rating to a “neutral” rating in a report on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Cardiovascular Systems presently has an average rating of “Buy” and a consensus target price of $23.71.

The company’s market cap is $804.02 million. The stock’s 50 day moving average price is $20.37 and its 200-day moving average price is $15.17.

Cardiovascular Systems (NASDAQ:CSII) last posted its earnings results on Wednesday, August 3rd. The medical device company reported ($0.15) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.20) by $0.05. The company had revenue of $48.50 million for the quarter, compared to the consensus estimate of $46.01 million. During the same period last year, the company posted ($0.27) earnings per share. The firm’s revenue for the quarter was up .0% compared to the same quarter last year. On average, equities research analysts expect that Cardiovascular Systems Inc. will post ($0.62) earnings per share for the current fiscal year.

In related news, SVP Paul A. Koehn sold 4,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $22.17, for a total value of $88,680.00. Following the completion of the transaction, the senior vice president now directly owns 102,652 shares of the company’s stock, valued at approximately $2,275,794.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.